Stella Pharma Corporation
Notice of Complete Payment for New Shares and Stock Acquisition Rights Issued under the Stock and Stock Acquisition Rights Issuance Program — Third Allotment to a Third Party
Payment completed for 1,000,000 new shares issued under the third allotment. Issue price 299 yen, total funds 299 million yen. Stock acquisition rights 10,500 units (potential shares 1,050,000 shares), exercise price 455 yen, payment date 2026/08/31, expiration 2030/08/31. Allottee: CVI Investments, Inc.
Key Figures
- 1,000,000 shares: Number of new shares issued in the third allotment
- 299,000,000 yen: Funds raised from the issuance
- 10,500 units: Total stock acquisition rights (each with 100 shares, potential shares 1,050,000)
AI要約
Section headline
This release notifies the completion of payment for the third allotment of new shares and stock acquisition rights under the Stock and Stock Acquisition Rights Issuance Program. The allottees are CVI Investments, Inc., an American institutional investor, and key points such as payment date, issue overview, funds raised, potential shares, and exercise period are listed.
Section 2 heading
The issuance of new shares has completed the financing, and changes in the capital structure are expected as part of future capital policy. Stock acquisition rights may cause potential dilution, but the exercise period is set from 2026/9/1 to 2030/8/31, positioning it as part of long-term capital operations.
Stella Pharma Corporation
Company overview · Stock price · Financial data · All IR
